The Recall Desk

Hazard

Excess Content recalls

1 recall in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
1
Critical
0
Severe
0
Most recent
2026-10-28

Of the 1 excess content recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all excess content recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

1–1 of 1

  • ModerateFDA (Drugs)·D-0049-2027·2026-10-28

    Viatris Recalls Telmisartan and Amlodipine Tablets Due to Superpotent Drug Risk

    Viatris is recalling 21,620 bottles of Telmisartan and Amlodipine tablets because the Telmisartan content may exceed specifications.

    Product
    TELMISARTAN AND AMLODIPINE — TELMISARTAN AND AMLODIPINE (TELMISARTAN AND AMLODIPINE)
    Category
    Drug
    Distribution
    Distributed nationwide